NEW YORK, March 14 - Ciphergen Biosystems of Fremont, Calif., said Wednesday it opened a new center in Malvern, Pa., to conduct proteomic research for the company’s customers.

The Biomarker Discovery Center’s first project will entail a clinical stratification pilot study for an unnamed pharmaceutical company. The center will also support the company’s cancer biomarker project with Johns Hopkins School of Medicine. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.